Grant: Doctoral Research Award: Canada Graduate Scholarships
McGill University
$105,000.00
Rare variants in syndromic ciliopathy genes as novel causes of isolated renal disease in adults
FY 2022-23
Summary
Chronic kidney disease affects approximately one in ten Canadians and puts an enormous strain on the public health care system. Renal ciliopathies are a group of autosomal-recessive ciliopathies that cause chronic kidney disease in children and young adults. While individually rare, the collective disease burden is 1 in 50,000 in Canada, constituting the most common cause of end-stage renal disease (ESRD) in the first three decades of life. Genetic kidney disease in children is particularly devastating, often presenting with an unremitting course towards complete loss of kidney function. Many of the causal gene mutations have been identified, but many are still unknown. This highlights the urgent need to identify patients at risk of chronic kidney disease and to develop new therapies that prevent progression to complete renal failure.
My proposed research project at the McGill University Health Centre aims to improve the diagnosis of genetic kidney disease and the understanding of these disease mechanisms. Using genetic analysis, I have identified novel causes of isolated renal ciliopathies due to rare mutations in the genes C2CD3 and CC2D2A. Our goal is to elucidate the role of these genes using patient-derived cells and zebrafish animal models. Specifically, I will evaluate the effect of each patient mutation in these genes to understand the disease-causing mechanism. By combining genetic and functional testing, I will establish a molecular genetic diagnosis in patients with unsolved clinical presentations. These models can then be used to screen for new drug therapies. We expect this work to lay a foundation for the development of new treatment options for hereditary forms of kidney disease, for which currently no treatment exists.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
475803
Name
Sentell Zachary T
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Rare variants in syndromic ciliopathy genes as novel causes of isolated renal disease in adults
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Chronic Kidney Disease; Crispr-Cas9; Exome Analysis; Genetics; Mendelian Inheritance; Molecular Diagnostics; Next-Generation Sequencing; Patient-Derived Cells; Precision Medicine; Zebrafish
Abstract
Chronic kidney disease affects approximately one in ten Canadians and puts an enormous strain on the public health care system. Renal ciliopathies are a group of autosomal-recessive ciliopathies that cause chronic kidney disease in children and young adults. While individually rare, the collective disease burden is 1 in 50,000 in Canada, constituting the most common cause of end-stage renal disease (ESRD) in the first three decades of life. Genetic kidney disease in children is particularly devastating, often presenting with an unremitting course towards complete loss of kidney function. Many of the causal gene mutations have been identified, but many are still unknown. This highlights the urgent need to identify patients at risk of chronic kidney disease and to develop new therapies that prevent progression to complete renal failure.
My proposed research project at the McGill University Health Centre aims to improve the diagnosis of genetic kidney disease and the understanding of these disease mechanisms. Using genetic analysis, I have identified novel causes of isolated renal ciliopathies due to rare mutations in the genes C2CD3 and CC2D2A. Our goal is to elucidate the role of these genes using patient-derived cells and zebrafish animal models. Specifically, I will evaluate the effect of each patient mutation in these genes to understand the disease-causing mechanism. By combining genetic and functional testing, I will establish a molecular genetic diagnosis in patients with unsolved clinical presentations. These models can then be used to screen for new drug therapies. We expect this work to lay a foundation for the development of new treatment options for hereditary forms of kidney disease, for which currently no treatment exists.
Competitiondate
202211
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Sentell, Zachary T
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~